Financial Management Professionals’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.24K Buy
69
+45
+188% +$3.77K ﹤0.01% 652
2026
Q1
$1.92K Hold
24
﹤0.01% 737
2025
Q4
$2.05K Sell
24
-22
-48% -$1.8K ﹤0.01% 726
2025
Q3
$3.58K Sell
46
-14
-23% -$1.09K ﹤0.01% 635
2025
Q2
$4.69K Sell
60
-10
-14% -$746 ﹤0.01% 634
2025
Q1
$5.07K Buy
70
+63
+900% +$4.51K ﹤0.01% 634
2024
Q4
$518 Hold
7
﹤0.01% 885
2024
Q3
$0 Sell
7
-38
-84% -$2.76K ﹤0.01% 955
2024
Q2
$4K Sell
45
-37
-45% -$3.28K ﹤0.01% 611
2024
Q1
$8K Buy
82
+28
+52% +$2.35K ﹤0.01% 576
2023
Q4
$4K Hold
54
﹤0.01% 672
2023
Q3
$4K Sell
54
-182
-77% -$14.6K ﹤0.01% 624
2023
Q2
$22K Sell
236
-50
-17% -$4.35K ﹤0.01% 382
2023
Q1
$24K Buy
286
+152
+113% +$11.9K ﹤0.01% 388
2022
Q4
$10K Buy
134
+29
+28% +$2.23K ﹤0.01% 502
2022
Q3
$9K Buy
105
+38
+57% +$3.66K ﹤0.01% 502
2022
Q2
$6K Sell
67
-11
-14% -$1.14K ﹤0.01% 586
2022
Q1
$9K Sell
78
-20
-20% -$2.24K ﹤0.01% 544
2021
Q4
$13K Buy
98
+12
+14% +$1.4K ﹤0.01% 433
2021
Q3
$10K Buy
86
+32
+59% +$3.65K ﹤0.01% 474
2021
Q2
$6K Buy
+54
New +$5.09K ﹤0.01% 482

Other funds holding EW

Financial Management Professionals's EW Position: Q2 2026 in Review

Financial Management Professionals increased its Edwards Lifesciences (EW) stake by 188% in Q2 2026, buying an estimated $3.77K and bringing the position to 69 shares worth $6.24K. The position accounts for ﹤0.01% of the portfolio, ranked #652.

Financial Management Professionals first reported a position in EW in Q2 2021 and has held it in 21 quarters since. The position peaked at $24K in Q1 2023. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Financial Management Professionals held 69 shares of Edwards Lifesciences worth $6.24K as of Q2 2026.
  • Financial Management Professionals bought 45 Edwards Lifesciences shares in Q2 2026, an estimated $3.77K.
  • Edwards Lifesciences made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #652 holding.
  • Financial Management Professionals first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 21 quarters since.
  • Financial Management Professionals's Edwards Lifesciences position peaked at $24K in Q1 2023.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.